A heterogeneous multimodal ensemble framework for multi-omics breast cancer prognosis

Reza Bozorgpour , Mohammadreza Soltany Sadrabadi

Clinical Cancer Bulletin ›› 2026, Vol. 5 ›› Issue (1) : 16

PDF
Clinical Cancer Bulletin ›› 2026, Vol. 5 ›› Issue (1) :16 DOI: 10.1007/s44272-026-00068-0
Original Research
research-article
A heterogeneous multimodal ensemble framework for multi-omics breast cancer prognosis
Author information +
History +
PDF

Abstract

Purpose

Accurate breast cancer prognosis remains a major challenge in precision oncology due to tumor heterogeneity and the complexity of integrating high-dimensional multi-omics data. Although multimodal learning approaches have improved predictive performance by combining clinical and molecular information, many existing methods rely on a single ensemble strategy that remains susceptible to prediction variance and limited robustness in high-dimensional, low-sample-size biomedical datasets. This study investigated whether integrating complementary ensemble strategies within a unified multimodal framework could improve the robustness and predictive performance of breast cancer prognosis.

Methods

A heterogeneous multimodal ensemble framework was developed in which stacking was used to integrate complementary information from clinical, gene expression, and copy number variation (CNV) data through meta-learning, while bagging was incorporated to stabilize the meta-learning process via bootstrap aggregation. The outputs of the stacking and bagging branches were combined using weighted probability fusion. The framework was evaluated on the METABRIC breast cancer cohort and compared with unimodal models and a conventional stacking ensemble using an independent test set and stratified tenfold cross-validation.

Results

The proposed hybrid framework achieved a ROC-AUC of 0.936, outperforming unimodal clinical and molecular models (ROC-AUC = 0.8140.885) and the conventional stacking ensemble (ROC-AUC = 0.898). Stratified tenfold cross-validation further demonstrated consistent improvements in mean ROC-AUC, recall, F1-score, balanced accuracy, and Matthews correlation coefficient, indicating improved robustness and stable performance across the internal validation folds. On the independent test set, the hybrid framework reduced false-negative predictions and increased sensitivity relative to the stacking ensemble, demonstrating a more favorable balance between identifying high-risk patients and maintaining overall predictive performance.

Conclusion

Rather than introducing a new ensemble algorithm, this study demonstrates that assigning complementary roles to stacking multimodal information integration and bagging for prediction stabilization provides an effective and robust framework for multi-omics breast cancer prognosis. The proposed hybrid strategy consistently improved predictive performance and robustness compared with conventional stacking while demonstrating stable performance across internal validation, supporting the use of complementary ensemble paradigms for multimodal prediction in precision oncology.

Keywords

Breast cancer prognosis / Multi-omics data integration / Multimodal deep learning / Ensemble learning / Hybrid stacking–bagging / Copy number variation

Cite this article

Download citation ▾
Reza Bozorgpour, Mohammadreza Soltany Sadrabadi. A heterogeneous multimodal ensemble framework for multi-omics breast cancer prognosis. Clinical Cancer Bulletin, 2026, 5 (1) : 16 DOI:10.1007/s44272-026-00068-0

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

Kleinlein R, Riaño D. Persistence of data-driven knowledge to predict breast cancer survival. Int J Med Inform, 2019, 129: 303-311

[2]

Arya N, Saha S. Multi-modal classification for human breast cancer prognosis prediction: proposal of deep-learning based stacked ensemble model. IEEE/ACM Trans Comput Biol Bioinform, 2022, 19(2): 1032-1041

[3]

Kumar S, Sharma S. Sub-classification of invasive and non-invasive cancer from magnification independent histopathological images using hybrid neural networks. Evol Intell, 2022, 15(3): 1531-1543

[4]

Gucalp A, Traina TA, Eisner JR, et al.. Male breast cancer: a disease distinct from female breast cancer. Breast Cancer Res Treat, 2019, 173(1): 37-48

[5]

Sung H, Filho AM, Laversanne M, et al.. Global cancer statistics 2024: GLOBOCAN estimates of incidence and mortality worldwide for 34 cancers in 186 countries. CA Cancer J Clin, 2026, 76(4 ArticleID: e70090

[6]

American Cancer Society. Cancer facts & figures 2026, 2026, Atlanta, American Cancer Society

[7]

Centers for Disease Control and Prevention. U.S. cancer statistics female breast cancer stat bite. U.S. Department of Health and Human Services, 2026. https://www.cdc.gov/united-states-cancer-statistics/publications/breast-cancer-stat-bite.html.

[8]

Siotos C, McColl M, Psoter K, et al.. Tumor site and breast cancer prognosis. Clin Breast Cancer, 2018, 18(5): e1045-e1052

[9]

Wei LS, Niraula D, Gates EDH, et al.. Artificial intelligence (AI) and machine learning (ML) in precision oncology: a review on enhancing discoverability through multiomics integration. Br J Radiol, 2023, 96(1150): 20230211

[10]

Catalano M, D’Angelo A, De Logu F, et al.. Navigating cancer complexity: integrative multi-omics methodologies for clinical insights. Clin Med Insights Oncol, 2025, 19: 11795549251384582

[11]

Sartori F, Codicè F, Caranzano I, et al.. A comprehensive review of deep learning applications with multi-omics data in cancer research. Genes (Basel), 2025, 16(6 ArticleID: 648

[12]

Hsu CY, Askar S, Alshkarchy SS, et al.. AI-driven multi-omics integration in precision oncology: bridging the data deluge to clinical decisions. Clin Exp Med, 2025, 26(1 ArticleID: 29

[13]

Mohr AE, Ortega-Santos CP, Whisner CM, et al.. Navigating challenges and opportunities in multi-omics integration for personalized healthcare. Biomedicines, 2024, 12(7 ArticleID: 1496

[14]

Muneer A, Waqas M, Saad MB, et al. From classical machine learning to emerging foundation models: review on multimodal data integration for cancer research. ArXiv. 2025:arXiv:2507.09028v2.

[15]

Baião AR, Cai ZX, Poulos RC, et al.. A technical review of multi-omics data integration methods: from classical statistical to deep generative approaches. Brief Bioinform, 2025, 26(4 ArticleID: bbaf355

[16]

Ran DS, Li J, Zhao MM, et al.. Artificial intelligence integrates multi-omics data for precision stratification and drug resistance prediction in breast cancer. Front Oncol, 2025, 15: 1612474

[17]

Malik S, Patro SGK, Al-Nussairi AKJ, et al.. A unified multi modal transformer framework for breast cancer recurrence prediction and survival analysis. Sci Rep, 2026, 16 ArticleID: 8334

[18]

Tran D, Nguyen H, Pham VD, et al.. A comprehensive review of cancer survival prediction using multi-omics integration and clinical variables. Brief Bioinform, 2025, 26(2 ArticleID: bbaf150

[19]

Flores JE, Claborne DM, Weller ZD, et al.. Missing data in multi-omics integration: recent advances through artificial intelligence. Front Artif Intell, 2023, 6: 1098308

[20]

Jennings C, Broad A, Godson L, et al. Machine learning-based multimodal prognostic models integrating pathology images and high-throughput omic data for overall survival prediction in cancer: a systematic review. 2025: 2507.16876. https://arxiv.org/abs/2507.16876

[21]

Zhuang LT, Park SH, Skates SJ, et al.. Advancing precision oncology through modeling of longitudinal and multimodal data. IEEE Rev Biomed Eng, 2026, 19: 182-200

[22]

Hemme CL, Atoyan J, Cai A, et al.. Challenges and opportunities in multi-omics data acquisition and analysis: toward integrative solutions. Biomolecules, 2026, 16(2 ArticleID: 271

[23]

Shen YX, Zhang PD, Luo JL, et al.. Artificial intelligence drives advances in multi-omics analysis and precision medicine for sepsis. Biomedicines, 2026, 14(2 ArticleID: 261

[24]

Nakach FZ, Idri A, Goceri E. A comprehensive investigation of multimodal deep learning fusion strategies for breast cancer classification. Artif Intell Rev, 2024, 57(12): 327

[25]

Bigdeli A, Faryabi RB, Sacan A. Leveraging machine learning for classifying the pathogenicity of genetic variants in cancer genomics and precision medicine. Drexel University Libraries, Doctor of Philosophy (Ph.D.), 2025. https://doi.org/10.17918/00011034

[26]

Hamamoto R, Koyama T, Takahashi S, et al.. Implementing generative artificial intelligence in precision oncology: safety, governance, and significance. J Hematol Oncol, 2026, 19(1 ArticleID: 14

[27]

Yetgin A. Revolutionizing multi-omics analysis with artificial intelligence and data processing. Quant Biol, 2025, 13(3 ArticleID: e70002

[28]

Wei TR, Yan YL. Multimodal medical imaging AI for breast cancer diagnosis: a comprehensive review. Intell Oncol, 2026, 2(1): 100037

[29]

Chua BN, Thng DHK, Toh TB, et al.. Artificial intelligence for breast cancer management. Commun Med, 2026, 6: 79

[30]

Ibrahim AM, Li JQ, Akhtar F, et al.. A multi-modal deep learning framework for enhanced breast cancer diagnosis using mammograms and clinical data. Sci Rep, 2026, 16: 17175

[31]

Chang YW, Ryu JK, An JK, et al.. Artificial intelligence for breast cancer screening in mammography (AI-STREAM): preliminary analysis of a prospective multicenter cohort study. Nat Commun, 2025, 16(1): 2248

[32]

Frazer HML, Hopper JL, Nguyen TL, et al.. AI-based BRAIx risk score for the intermediate-term prediction of breast cancer: a population cohort study. Lancet Digit Health, 2026, 8(4 ArticleID: 100987

[33]

Gommers J, Hernström V, Josefsson V, et al.. Interval cancer, sensitivity, and specificity comparing AI-supported mammography screening with standard double reading without AI in the MASAI study: a randomised, controlled, non-inferiority, single-blinded, population-based, screening-accuracy trial. Lancet, 2026, 407(10527): 505-514

[34]

Nasarudin NA, Al-Jasmi F, Abdul Aziz NH, et al. An improved deep learning algorithm for breast cancer survival prediction based on multi-omics data. F1000Res. 2025;14:765. https://doi.org/10.12688/f1000research.166682.3.

[35]

Wu ZX, Yao SN, Jin LL, et al.. An interpretable machine learning model for predicting 5-year survival in breast cancer based on integration of proteomics and clinical data. IMetaMed, 2025, 1(2 ArticleID: e70010

[36]

Uma Kandan S, Alketbi MM, Al AZ. Multi-input CNN: a deep learning-based approach for predicting breast cancer prognosis using multi-modal data. Discover Data, 2025, 3(1): 2

[37]

Chtouki K, Rhanoui M, Mikram M, et al. Supervised machine learning for Breast cancer risk factors analysis and survival prediction. Proceedings of the 6th international conference on big data and internet of things. Cham: Springer International Publishing; 2023:59–71. https://doi.org/10.1007/978-3-031-28387-1_6.

[38]

Vale-Silva LA, Rohr K. Long-term cancer survival prediction using multimodal deep learning. Sci Rep, 2021, 11(1 ArticleID: 13505

[39]

Tong L, Mitchel J, Chatlin K, et al.. Deep learning based feature-level integration of multi-omics data for breast cancer patients survival analysis. BMC Med Inform Decis Mak, 2020, 20(1): 225

[40]

Sucre A, Calle Sánchez X, Perez-Herrera LV, et al.. Multimodal fusion strategies for survival prediction in breast cancer: a comparative deep learning study. Comput Struct Biotechnol J, 2025, 27: 4505-4516

[41]

Dogan RO. A dual-stage multimodal alignment approach for robust breast cancer diagnosis via visual–textual computing. Appl Sci, 2026, 16(12): 5934

[42]

Palmal S, Arya N, Saha S, et al.. Breast cancer survival prognosis using the graph convolutional network with Choquet fuzzy integral. Sci Rep, 2023, 13(1): 14757

[43]

Yao XK, Wang T, Yang Q, et al.. Multi-omics data integration for improved cancer subtyping via denoising autoencoder-based multi-kernel learning. Genes, 2025, 16(11): 1246

[44]

Wen G, Li LM. Coformersurv: collaborative transformer for multi-omics survival analysis. PLoS Comput Biol, 2026, 22(1 ArticleID: e1013875

[45]

Al Mansour AGM, Alshomrani F, Alfahaid A, et al.. MammoViT: a custom vision transformer architecture for accurate BIRADS classification in mammogram analysis. Diagnostics, 2025, 15(3): 285

[46]

Wang W, Jiang R, Cui N, et al.. Semi-supervised vision transformer with adaptive token sampling for breast cancer classification. Front Pharmacol, 2022, 13 ArticleID: 929755

[47]

Vorontsov E, Bozkurt A, Casson A, et al.. A foundation model for clinical-grade computational pathology and rare cancers detection. Nat Med, 2024, 30(10): 2924-2935

[48]

Dai DW, Zhang YH, Yang QL, et al.. Pathologyvlm: a large vision-language model for pathology image understanding. Artif Intell Rev, 2025, 58(6): 186

[49]

Ke Q, Yap WS, Tee YK, et al.. Advanced deep learning for multi-class colorectal cancer histopathology: integrating transfer learning and ensemble methods. Quant Imaging Med Surg, 2025, 15(3): 2329-2346

[50]

Pinheiro JMH, Becker M. Breast cancer classification using gradient boosting algorithms focusing on reducing the false negative and SHAP for explainability. 2024: 2403.09548. https://arxiv.org/abs/2403.09548

[51]

Sampson A, James A, Tripathi V. Optimizing breast cancer prediction through stacking ensemble machine learning models: a comparative analysis. J Electr Syst Inf Technol, 2026, 13(1): 9

[52]

Saharan S, Ahmad Wani N, Chatterji S, et al.. A deep learning and explainable artificial intelligence based scheme for breast cancer detection. Sci Rep, 2025, 15 ArticleID: 32125

[53]

Mukherjee A, Russell R, Chin SF, et al.. Associations between genomic stratification of breast cancer and centrally reviewed tumour pathology in the METABRIC cohort. npj Breast Cancer, 2018, 4 ArticleID: 5

[54]

Mustafa E, Jadoon EK, Khaliq-Uz-Zaman S, et al.. An ensembled framework for human breast cancer survivability prediction using deep learning. Diagnostics (Basel), 2023, 13(10 ArticleID: 1688

[55]

Al-Helali B, Chen Q, Xue B, et al.. A new imputation method based on genetic programming and weighted KNN for symbolic regression with incomplete data. Soft Comput, 2021, 25(8): 5993-6012

[56]

Sun DD, Wang MH, Li A. A multimodal deep neural network for human breast cancer prognosis prediction by integrating multi-dimensional data. IEEE-ACM Trans Comput Biol Bioinform, 2019, 16(3): 841-850

[57]

Gevaert O, de Smet F, Timmerman D, et al.. Predicting the prognosis of breast cancer by integrating clinical and microarray data with Bayesian networks. Bioinformatics, 2006, 22(14): e184-e190

[58]

Singh D, Singh B. Investigating the impact of data normalization on classification performance. Appl Soft Comput, 2020, 97 ArticleID: 105524

[59]

Verghese SL, Liao IY, Maul TH, et al.. An empirical study of several information theoretic based feature extraction methods for classifying high dimensional low sample size data. IEEE Access, 2021, 9: 69157-69172

[60]

Mostavi M, Chiu YC, Huang YF, et al.. Convolutional neural network models for cancer type prediction based on gene expression. BMC Med Genom, 2020, 13(5): 44

[61]

Eroğlu Y, Yildirim M, Çinar A. Convolutional Neural Networks based classification of breast ultrasonography images by hybrid method with respect to benign, malignant, and normal using mRMR. Comput Biol Med, 2021, 133 ArticleID: 104407

[62]

Kiranyaz S, Avci O, Abdeljaber O, et al.. 1D convolutional neural networks and applications: a survey. Mech Syst Signal Process, 2021, 151 ArticleID: 107398

RIGHTS & PERMISSIONS

The Author(s)

PDF

5

Accesses

0

Citation

Detail

Sections
Recommended

/